Cybin, Inc. (TSE:CYBN) has released an update.
Cybin Inc., a biopharmaceutical company focusing on psychedelic-based therapeutics for mental health, announces their CEO Doug Drysdale’s participation in the Alliance Global Partners Healthcare Company Showcase, where he will speak via a live webcast on May 21, 2024. Cybin is developing treatments such as CYB003 and CYB004 for major depressive and generalized anxiety disorders, respectively, and operates across North America and Europe. The event aims to shed light on Cybin’s innovative approaches and ongoing research in revolutionizing mental healthcare.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
